Morgan Stanley »

Candel Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2026-03-31 $285k 58k 4.90
2025-12-31 $757k 134k 5.65
2025-09-30 $387k 76k 5.10
2025-06-30 $575k 114k 5.06
2024-12-31 $653k 75k 8.68
2024-09-30 $447k 64k 6.93
2024-06-30 $121k 20k 6.20
2022-12-31 $165 92 1.79
2022-06-30 $15k 4.6k 3.25
2022-03-31 $24k 4.7k 5.16